vs

Side-by-side financial comparison of GigaCloud Technology Inc (GCT) and IONIS PHARMACEUTICALS INC (IONS). Click either name above to swap in a different company.

GigaCloud Technology Inc is the larger business by last-quarter revenue ($332.6M vs $203.3M, roughly 1.6× IONIS PHARMACEUTICALS INC). GigaCloud Technology Inc runs the higher net margin — 11.2% vs -112.8%, a 124.0% gap on every dollar of revenue. On growth, GigaCloud Technology Inc posted the faster year-over-year revenue change (9.7% vs -10.3%). GigaCloud Technology Inc produced more free cash flow last quarter ($77.1M vs $-159.0M). Over the past eight quarters, GigaCloud Technology Inc's revenue compounded faster (36.6% CAGR vs 30.4%).

GigaCloud Technology Inc. is an American e-commerce company that helps retailers buy and sell big and bulky, non-standardized items such as furniture, appliances, and fitness equipment. They own a business-to-business online marketplace and act as a middleman by handling sales, logistics and also delivery to end customers. GigaCloud is headquartered in El Monte, California, and is listed on the Nasdaq stock exchange since August 2022.

Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015.

GCT vs IONS — Head-to-Head

Bigger by revenue
GCT
GCT
1.6× larger
GCT
$332.6M
$203.3M
IONS
Growing faster (revenue YoY)
GCT
GCT
+19.9% gap
GCT
9.7%
-10.3%
IONS
Higher net margin
GCT
GCT
124.0% more per $
GCT
11.2%
-112.8%
IONS
More free cash flow
GCT
GCT
$236.1M more FCF
GCT
$77.1M
$-159.0M
IONS
Faster 2-yr revenue CAGR
GCT
GCT
Annualised
GCT
36.6%
30.4%
IONS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GCT
GCT
IONS
IONS
Revenue
$332.6M
$203.3M
Net Profit
$37.2M
$-229.4M
Gross Margin
23.2%
96.1%
Operating Margin
12.2%
-105.5%
Net Margin
11.2%
-112.8%
Revenue YoY
9.7%
-10.3%
Net Profit YoY
-8.6%
-119.8%
EPS (diluted)
$0.99
$-1.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GCT
GCT
IONS
IONS
Q4 25
$203.3M
Q3 25
$332.6M
$156.7M
Q2 25
$322.6M
$452.0M
Q1 25
$271.9M
$131.6M
Q4 24
$295.8M
$226.6M
Q3 24
$303.3M
$133.8M
Q2 24
$310.9M
$225.3M
Q1 24
$251.1M
$119.5M
Net Profit
GCT
GCT
IONS
IONS
Q4 25
$-229.4M
Q3 25
$37.2M
$-128.6M
Q2 25
$34.6M
$123.6M
Q1 25
$27.1M
$-146.9M
Q4 24
$31.0M
$-104.3M
Q3 24
$40.7M
$-140.5M
Q2 24
$27.0M
$-66.3M
Q1 24
$27.2M
$-142.8M
Gross Margin
GCT
GCT
IONS
IONS
Q4 25
96.1%
Q3 25
23.2%
98.5%
Q2 25
23.9%
99.1%
Q1 25
23.4%
98.9%
Q4 24
22.0%
98.3%
Q3 24
25.5%
99.2%
Q2 24
24.6%
98.2%
Q1 24
26.5%
98.2%
Operating Margin
GCT
GCT
IONS
IONS
Q4 25
-105.5%
Q3 25
12.2%
-102.2%
Q2 25
11.1%
30.9%
Q1 25
10.4%
-111.6%
Q4 24
9.3%
-48.9%
Q3 24
13.4%
-111.1%
Q2 24
8.8%
-29.3%
Q1 24
13.9%
-125.1%
Net Margin
GCT
GCT
IONS
IONS
Q4 25
-112.8%
Q3 25
11.2%
-82.1%
Q2 25
10.7%
27.3%
Q1 25
10.0%
-111.6%
Q4 24
10.5%
-46.1%
Q3 24
13.4%
-105.0%
Q2 24
8.7%
-29.4%
Q1 24
10.8%
-119.5%
EPS (diluted)
GCT
GCT
IONS
IONS
Q4 25
$-1.35
Q3 25
$0.99
$-0.80
Q2 25
$0.91
$0.70
Q1 25
$0.68
$-0.93
Q4 24
$0.76
$-0.66
Q3 24
$0.98
$-0.95
Q2 24
$0.65
$-0.45
Q1 24
$0.66
$-0.98

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GCT
GCT
IONS
IONS
Cash + ST InvestmentsLiquidity on hand
$365.9M
$2.7B
Total DebtLower is stronger
$1.8B
Stockholders' EquityBook value
$457.3M
$489.1M
Total Assets
$1.1B
$3.5B
Debt / EquityLower = less leverage
3.71×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GCT
GCT
IONS
IONS
Q4 25
$2.7B
Q3 25
$365.9M
$2.2B
Q2 25
$303.0M
$2.3B
Q1 25
$286.8M
$2.1B
Q4 24
$302.4M
$2.3B
Q3 24
$259.8M
$2.5B
Q2 24
$207.8M
$2.1B
Q1 24
$195.3M
$2.2B
Total Debt
GCT
GCT
IONS
IONS
Q4 25
$1.8B
Q3 25
Q2 25
Q1 25
Q4 24
$1.3B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
GCT
GCT
IONS
IONS
Q4 25
$489.1M
Q3 25
$457.3M
$618.0M
Q2 25
$431.4M
$631.7M
Q1 25
$412.9M
$475.7M
Q4 24
$405.2M
$588.4M
Q3 24
$400.4M
$662.5M
Q2 24
$358.4M
$263.7M
Q1 24
$317.8M
$296.5M
Total Assets
GCT
GCT
IONS
IONS
Q4 25
$3.5B
Q3 25
$1.1B
$3.0B
Q2 25
$1.1B
$3.0B
Q1 25
$1.1B
$2.8B
Q4 24
$1.1B
$3.0B
Q3 24
$1.1B
$3.1B
Q2 24
$1.1B
$2.7B
Q1 24
$977.6M
$2.8B
Debt / Equity
GCT
GCT
IONS
IONS
Q4 25
3.71×
Q3 25
Q2 25
Q1 25
Q4 24
2.13×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GCT
GCT
IONS
IONS
Operating Cash FlowLast quarter
$78.3M
$-137.7M
Free Cash FlowOCF − Capex
$77.1M
$-159.0M
FCF MarginFCF / Revenue
23.2%
-78.2%
Capex IntensityCapex / Revenue
0.4%
10.5%
Cash ConversionOCF / Net Profit
2.10×
TTM Free Cash FlowTrailing 4 quarters
$188.1M
$-320.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GCT
GCT
IONS
IONS
Q4 25
$-137.7M
Q3 25
$78.3M
$-131.4M
Q2 25
$38.6M
$151.3M
Q1 25
$9.4M
$-150.8M
Q4 24
$68.4M
$-116.1M
Q3 24
$55.2M
$-115.0M
Q2 24
$19.1M
$-119.9M
Q1 24
$15.3M
$-149.9M
Free Cash Flow
GCT
GCT
IONS
IONS
Q4 25
$-159.0M
Q3 25
$77.1M
$-136.7M
Q2 25
$37.0M
$139.0M
Q1 25
$7.0M
$-163.4M
Q4 24
$66.9M
$-141.6M
Q3 24
$51.4M
$-124.0M
Q2 24
$12.9M
$-126.1M
Q1 24
$11.3M
$-154.4M
FCF Margin
GCT
GCT
IONS
IONS
Q4 25
-78.2%
Q3 25
23.2%
-87.2%
Q2 25
11.5%
30.8%
Q1 25
2.6%
-124.1%
Q4 24
22.6%
-62.5%
Q3 24
16.9%
-92.7%
Q2 24
4.2%
-56.0%
Q1 24
4.5%
-129.2%
Capex Intensity
GCT
GCT
IONS
IONS
Q4 25
10.5%
Q3 25
0.4%
3.4%
Q2 25
0.5%
2.7%
Q1 25
0.9%
9.6%
Q4 24
0.5%
11.3%
Q3 24
1.3%
6.8%
Q2 24
2.0%
2.8%
Q1 24
1.6%
3.8%
Cash Conversion
GCT
GCT
IONS
IONS
Q4 25
Q3 25
2.10×
Q2 25
1.12×
1.22×
Q1 25
0.35×
Q4 24
2.21×
Q3 24
1.36×
Q2 24
0.71×
Q1 24
0.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GCT
GCT

Services$108.4M33%
Transferred Over Time$89.8M27%
Product Sales To B$50.1M15%
Last Mile Delivery Service$49.2M15%
Warehousing Service$14.2M4%
Ocean Transportation Service$9.0M3%
Platform Commission$4.9M1%
Drayage Service$3.2M1%

IONS
IONS

Products$58.0M29%
Spinraza Royalties$54.0M27%
Collaborative Agreement Revenue$52.4M26%
Wainus Royalties$16.0M8%
Wainua Joint Development Revenue$9.6M5%
Other Commercial$7.6M4%
Other Royalties$5.7M3%

Related Comparisons